Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
Daye Cheng,1 Bin Liang,2 Yiwen Hao,1 Wenling Zhou1 1Department of Transfusion, First Hospital of China Medical University, Shenyang, 2Department of Clinical Laboratory, High Vocational Technological College, China Medical University, Shenyang, People’s Republic of China Objective: Human...
Guardado en:
Autores principales: | Cheng D, Liang B, Hao Y, Zhou W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39e3ce06544a4501bc2649ea8851058f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selective estrogen receptor modulators: tissue specificity and clinical utility
por: Martinkovich S, et al.
Publicado: (2014) -
Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019) -
Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
por: Liang JH, et al.
Publicado: (2018) -
Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
por: Chen J, et al.
Publicado: (2019) -
Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)